Grant-Kels JM - Search Results

1

Dysplastic nevus part I: Historical perspective, classification, and epidemiology.

Drozdowski R, Spaccarelli N, Peters MS, Grant-Kels JM. Drozdowski R, et al. J Am Acad Dermatol. 2023 Jan;88(1):1-10. doi: 10.1016/j.jaad.2022.04.068. Epub 2022 Aug 28. J Am Acad Dermatol. 2023. PMID: 36038073 Review.

2

Spitz nevi.

Casso EM, Grin-Jorgensen CM, Grant-Kels JM. Casso EM, et al. J Am Acad Dermatol. 1992 Dec;27(6 Pt 1):901-13. doi: 10.1016/0190-9622(92)70286-o. J Am Acad Dermatol. 1992. PMID: 1479095 Review.

3

The six classic childhood exanthems: a review and update.

Bialecki C, Feder HM Jr, Grant-Kels JM. Bialecki C, et al. J Am Acad Dermatol. 1989 Nov;21(5 Pt 1):891-903. doi: 10.1016/s0190-9622(89)70275-9. J Am Acad Dermatol. 1989. PMID: 2681288 Review.

4

Ocular melanomas and melanocytic lesions of the eye.

Grin JM, Grant-Kels JM, Grin CM, Berke A, Kels BD. Grin JM, et al. J Am Acad Dermatol. 1998 May;38(5 Pt 1):716-30. doi: 10.1016/s0190-9622(98)70201-4. J Am Acad Dermatol. 1998. PMID: 9591817 Review.

5

Practical evaluation and management of cutaneous lymphoma.

Fung MA, Murphy MJ, Hoss DM, Grant-Kels JM. Fung MA, et al. J Am Acad Dermatol. 2002 Mar;46(3):325-57; quiz, 358-60. doi: 10.1067/mjd.2002.121355. J Am Acad Dermatol. 2002. PMID: 11862169 Review.

6

Molecular diagnosis of a benign proliferative nodule developing in a congenital melanocytic nevus in a 3-month-old infant.

Murphy MJ, Jen M, Chang MW, Grant-Kels JM, Makkar H. Murphy MJ, et al. J Am Acad Dermatol. 2008 Sep;59(3):518-23. doi: 10.1016/j.jaad.2008.05.011. Epub 2008 Jul 21. J Am Acad Dermatol. 2008. PMID: 18640742

7

A picture is worth a thousand words: ethical dilemmas presented by storing digital photographs in electronic health records.

Lakdawala N, Bercovitch L, Grant-Kels JM. Lakdawala N, et al. J Am Acad Dermatol. 2013 Sep;69(3):473-5. doi: 10.1016/j.jaad.2013.03.017. J Am Acad Dermatol. 2013. PMID: 23957967 No abstract available.

8

Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor-alfa antagonists: Part I. Risks associated with tumor necrosis factor-alfa antagonists.

Chirch LM, Cataline PR, Dieckhaus KD, Grant-Kels JM. Chirch LM, et al. J Am Acad Dermatol. 2014 Jul;71(1):1.e1-8; quiz 1.e8-9, 10. doi: 10.1016/j.jaad.2014.01.875. J Am Acad Dermatol. 2014. PMID: 24947698

9

Reply to: "Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors".

Chirch L, Dieckhaus K, Grant-Kels JM. Chirch L, et al. J Am Acad Dermatol. 2015 Apr;72(4):743. doi: 10.1016/j.jaad.2014.08.055. J Am Acad Dermatol. 2015. PMID: 25773421 No abstract available.

10

Dysplastic nevus: Fact and fiction.

Rosendahl CO, Grant-Kels JM, Que SK. Rosendahl CO, et al. J Am Acad Dermatol. 2015 Sep;73(3):507-12. doi: 10.1016/j.jaad.2015.04.029. Epub 2015 May 30. J Am Acad Dermatol. 2015. PMID: 26037217 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

557 results

Search Page